NCT03175939View on ClinicalTrials.gov

Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

April 1, 1998

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2014

Conditions
Nasopharyngeal Cancer
Interventions
RADIATION

Radiotherapy

External beam radiotherapy with curative intent, at least 66 Gy

DRUG

Cisplatin

cisplatin IV injection over 3 hours

DRUG

5-FU

5-FU IV 24 hours continuous infusion

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT03175939 - Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter